Literature DB >> 8123169

Polycystic ovaries in female-to-male transsexuals.

T D Pache, B C Fauser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8123169

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  5 in total

1.  Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.

Authors:  Aimee S L Caldwell; Melissa C Edwards; Reena Desai; Mark Jimenez; Robert B Gilchrist; David J Handelsman; Kirsty A Walters
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

2.  CMKLR1 deficiency maintains ovarian steroid production in mice treated chronically with dihydrotestosterone.

Authors:  Mi Tang; Chen Huang; Yu-Fei Wang; Pei-Gen Ren; Li Chen; Tian-Xia Xiao; Bao-Bei Wang; Yan-Fei Pan; Benjamin K Tsang; Brian A Zabel; Bao-Hua Ma; Hui-Ying Zhao; Jian V Zhang
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

3.  Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study).

Authors:  Eser Sefik Ozyurek; Tevfik Yoldemir; Gokhan Artar
Journal:  J Ovarian Res       Date:  2017-05-12       Impact factor: 4.234

Review 4.  The Mechanism of Androgen Actions in PCOS Etiology.

Authors:  Valentina Rodriguez Paris; Michael J Bertoldo
Journal:  Med Sci (Basel)       Date:  2019-08-28

5.  Tetragonia tetragonioides (Pall.) Kuntze Regulates Androgen Production in a Letrozole-Induced Polycystic Ovary Syndrome Model.

Authors:  Bo-Jeong Pyun; Hyun Yang; Eunjin Sohn; Song Yi Yu; Dongoh Lee; Dong Ho Jung; Byoung Seob Ko; Hye Won Lee
Journal:  Molecules       Date:  2018-05-14       Impact factor: 4.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.